Psilocybin
Bia Labate of the Chacruna Institute: Truffle Talks Episode 14
James sits down with Dr. Bia Labate to discuss the many projects of the Chacruna Institute. Dr. Beatriz Caiuby Labate (Bia Labate) is a queer Brazilian…
James sits down with Dr. Bia Labate to discuss the many projects of the Chacruna Institute.
Dr. Beatriz Caiuby Labate (Bia Labate) is a queer Brazilian anthropologist based in San Francisco.
She has a Ph.D. in social anthropology from the State University of Campinas (UNICAMP), Brazil. Her main areas of interest are the study of plant medicines, drug policy, shamanism, ritual, religion, and social justice.
She is Executive Director of the Chacruna Institute for Psychedelic Plant Medicines. She serves as Public Education and Culture Specialist at the Multidisciplinary Association for Psychedelic Studies (MAPS), and Adjunct Faculty at the East-West Psychology Program at the California Institute of Integral Studies (CIIS).
She is also a member of the Oregon Psilocybin Advisory Board’s Research Subcommittee, and Diversity, Culture, and Ethics Advisor at the Synthesis Institute. Additionally, she is a co-founder of the Interdisciplinary Group for Psychoactive Studies (NEIP) in Brazil and editor of its site. She is author, co-author, and co-editor of twenty-four books, two special-edition journals, and several peer-reviewed articles.
The post Bia Labate of the Chacruna Institute: Truffle Talks Episode 14 appeared first on Truffle Report.
psilocybin psychedelic psychoactive synthesis research-
Psychedelics7 days ago
Exploring Psilocybin’s Potential in Diabetes Management
-
Psychedelics7 days ago
All About the New Ketamine Trial at the University of Otago
-
Psychedelics1 week ago
Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
-
Law & Regulation1 week ago
Canada’s Optimi Health to ship psilocybin to New Zealand psychedelics research center
-
Law & Regulation1 week ago
Synaptogenix increases psilocybin stake with PsygaBio
-
Psychedelics7 days ago
The EU’s Plan for a €6.5M Study of Psychedelics To Treat Mental Disorders
-
Psychedelics7 days ago
Exploring Psilocybin’s Potential in Diabetes Management
-
Psychedelics7 days ago
The EU’s Plan for a €6.5M Study of Psychedelics To Treat Mental Disorders